Product Image

Ultra Gingko Plus Endurance Formula

Prince Of Peace
4.6
★ ★ ★ ★ ★
(1118 ratings)
Eleuthero 300 mg
Ginkgo
Product Image
Score43
A loosely focused endurance blend in which white mulberry and undisclosed proprietary dosing overshadow low ginkgo and modest rhodiola.
How scoring works
Quantity:30 Bottle(s) • (30 servings)
Goals:
Stress Relief
Energy
Productivity Boost
Cognitive Support

Score 43

A loosely focused endurance blend in which white mulberry and undisclosed proprietary dosing overshadow low ginkgo and modest rhodiola.
How scoring works
$16.10($0.53 per serving)
iHerb
$ 23.48
Pure Formulas
$ 18.79
Vitacost
$ 20.29
Amazon
$ 16.10
Walmart
$ 17.99
Report prices

Analysis

Eleuthero at 300 mg and rhodiola at 100 mg may support resilience during stress, although the rhodiola amount is modest. Ginkgo is present at only 40 mg, below the range usually expected from a stand-alone cognitive formula.

White mulberry accounts for 1,400 mg, even though it is not the main ingredient expected for energy or mental focus. The separate 1,840 mg proprietary blend further obscures how much of the formula can be evaluated from the label.

The liquid may appeal to people who prefer a ready-to-use botanical serving, but its goal alignment is scattered. It is a weak choice for ginkgo-focused use, vision support, or anyone who wants standardized adaptogen potency.

Who is it for
  • Adults seeking a broad liquid botanical blend
  • People more interested in stress stamina than targeted ginkgo use
Best for
  • General adaptogenic intent
  • A liquid alternative to capsules

Pros

  • Discloses 300 mg of eleuthero root extract
  • Includes rhodiola and ginkgo alongside eleuthero
  • Provides only 25 calories per serving

Cons

  • Ginkgo is low at 40 mg
  • Rhodiola is modest at 100 mg
  • A large proprietary blend obscures the formula
  • White mulberry dominates despite limited relevance to the stated goals
  • No botanical standardization is supplied

Warnings

  • Ginkgo may add to bleeding risk with anticoagulant or antiplatelet medicines.
  • Eleuthero and rhodiola may not suit people who are sensitive to stimulating botanicals or have blood-pressure concerns.

Nutrient quality

45 Lower impact

Eleuthero, rhodiola, and ginkgo offer plausible endurance support. Their modest doses, absent standardization, and a dominant white mulberry component weaken the formula.

.

Ingredient transparency

35 Lower impact

Some botanical amounts are disclosed, but a large proprietary blend remains hidden. Extract potency, complete contents, and inactive ingredients are unclear.

.

Customer satisfaction

66 High impact

The supplied average rating is strong and comes from a substantial rating pool. No firsthand experiences or recurring complaint details were provided, so consistency remains uncertain.

.

Value for money

32 Situational impact

The serving cost is hard to justify because the most relevant actives are modest or low. A large opaque blend and weakly aligned extras further reduce useful value.

.
Report analysis

Goals

Stress Relief
Impact
Moderate effect
B- Goal FitC- Strength of SupportC+ CoverageC- Formula Quality
Eleuthero · 300 mg

Eleuthero and rhodiola provide relevant adaptogenic support for stress-related fatigue and resilience. Their combination covers more than one stress-response need, but the rhodiola amount is modest.

White mulberry dominates the botanical serving despite weak relevance to stress relief. Missing extract ratios and active-marker percentages make the formula harder to judge consistently.

Study evidence
Eleuthero No effect 1 study
Energy
Impact
Moderate effect
B- Goal FitC- Strength of SupportC CoverageD+ Formula Quality

Eleuthero and rhodiola provide plausible stress-resilience support, while ginkgo may aid mental performance. The formula covers adaptogenic and cognitive pathways but does not directly support mitochondrial fuel production.

Eleuthero, rhodiola, and ginkgo amounts are modest or low, and no extract standardization is disclosed. A large white mulberry amount and a broad proprietary blend weaken the energy-specific balance.

Study evidence
Eleuthero Disputed 3 studies
Productivity Boost
Impact
Moderate effect
B- Goal FitD+ Strength of SupportC CoverageC- Formula Quality
Eleuthero · 300 mgEleuthero · 300 mg

Eleuthero provides a plausible stress-resilience and fatigue-support core, while Rhodiola and ginkgo add related cognitive intent. Human evidence is useful for standardized adaptogens, but none of the botanical marker profiles are disclosed.

Eleuthero reaches a practical amount, while Rhodiola and ginkgo appear low for stand-alone effects. A large white mulberry component and broad proprietary blend reduce focus on productivity.

Study evidence
Eleuthero No effect 1 study
Eleuthero Not classified

No linked studies yet.

Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Cognitive Support
Impact
Moderate effect
C Goal FitD- Strength of SupportC CoverageD- Formula Quality

Eleuthero and rhodiola offer adaptogenic support, while ginkgo may contribute to cerebral circulation. The eleuthero amount is the strongest cognitive-relevant part of the formula.

Rhodiola and ginkgo are underdosed and unstandardized, and a large proprietary blend obscures much of the formula. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Eleuthero No effect 1 study
Ginkgo Supportive 87 studies

Ingredients

IngredientAmount per serving
Calories
25 Calorie(s)
Total Carbohydrates
6 Gram(s)
Proprietary Blend
1840 mg
White Mulberry extract
1400 mg
Eleuthero (root) extract
300 mg
Rhodiola (root) extract
100 mg
Ginkgo (leaf) extract
40 mg
Adults 18–50 Dairy Free
Report overview
Eleuthero · 300 mg OverallScore74
D Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyB+ Value

The formula provides a useful amount of eleuthero root extract with clear dose disclosure. However, no eleutheroside percentage or extract ratio is provided, limiting confidence in extract consistency. Its near-median serving cost offers good value for the stated dose within a broader botanical blend.

Ginkgo · 40 mg OverallScore25
F Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyF Value

The ginkgo extract lacks active-marker percentages and a ginkgolic acid purity guarantee. Its specific amount is disclosed, but the daily dose is below the maintenance range. High cost and absent standardization make it poor value for ginkgo-focused use.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledCognitive Support forGinkgo
  2. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support forGinkgo
  3. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledCognitive Support forGinkgo
  4. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  5. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledCognitive Support Productivity Boost forGinkgo
  6. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  7. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  8. Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.
    Page JW; Findley J; Crognale MA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006
    Clinical trialVision Support forGinkgo
  9. Ginkgo biloba--an appraisal.
    Dubey AK; Shankar PR; Upadhyaya D; Deshpande VY · Kathmandu University medical journal (KUMJ) · 2007
    Narrative reviewVision Support forGinkgo
  10. Ginkgo biloba extract for age-related macular degeneration.
    Evans JR · The Cochrane database of systematic reviews · 2013
    Systematic review119 participants2 studies pooledVision Support forGinkgo
  11. No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study.
    Schaffler K; Wolf OT; Burkart M · Pharmacopsychiatry · 2014
    Randomized trial144 participantsCognitive Support Productivity Boost Stress Relief forEleuthero
  12. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  13. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  14. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  15. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  16. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity.
    Panossian A; Wikman G · Current clinical pharmacology · 2009
    Narrative reviewEnergy forEleuthero
  17. Randomized controlled trial of Siberian ginseng for chronic fatigue.
    Hartz AJ; Bentler S; Noyes R; Hoehns J; Logemann C; Sinift S; Butani Y; Wang W; Brake K; Ernst M; Kautzman H · Psychological medicine · 2004
    Randomized trial96 participantsEnergy forEleuthero
  18. The effect of eight weeks of supplementation with Eleutherococcus senticosus on endurance capacity and metabolism in human
    J Kuo, K W Chen, I S Cheng, P H Tsai, Y J Lu, N Y Lee · Chinese Journal of Physiology · 2010
    Randomized trial9 participantsEnergy forEleuthero
  19. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsProductivity Boost forGinkgo
  20. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  21. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  22. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  23. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  24. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo